Chemo Facts

Facts on Drugs Used in Chemotherapy

Arrow to the left Back to the Homepage

Active substance: Rituximab
Manufacturer: Genentech (USA) / Roche (Worldwide)
 

Extract from the prescribing information:

"Rituxan administration can result in serious, including fatal infusion reactions. Deaths within 24 hours of Rituxan infusion have occurred. Approximately 80% of fatal infusion reactions occurred in association with the first infusion."

The above has been extracted from the Rituximab prescribing information on the Genentech webpages.